Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GELITA Australia is a subsidiary of the global GELITA Group, specializing in the manufacture and supply of gelatine and collagen peptides for the pharmaceutical, healthcare, and food industries. The company operates a significant manufacturing facility in Beaudesert, Queensland, producing high-quality collagen proteins derived from natural raw materials. Their product portfolio includes bioactive collagen peptides designed for specific health benefits such as joint health, bone density, and skin elasticity. They also provide pharmaceutical-grade gelatine used extensively in the production of hard and soft capsules, as well as specialized medical applications like hemostats. GELITA Australia serves as a key hub for the Oceania region, providing technical expertise and innovative protein solutions to support the life sciences and nutrition sectors. The company is recognized for its commitment to scientific research, with numerous clinical studies validating the efficacy of its bioactive ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GELITA Australia.